Fisher Funds Management LTD Buys New Holdings in Humana Inc. (NYSE:HUM)

Fisher Funds Management LTD bought a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 67,300 shares of the insurance provider’s stock, valued at approximately $16,952,000. Fisher Funds Management LTD owned about 0.06% of Humana as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also bought and sold shares of HUM. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Centricity Wealth Management LLC acquired a new stake in Humana in the 4th quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new stake in Humana in the 3rd quarter valued at about $31,000. Your Advocates Ltd. LLP lifted its stake in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. Finally, Atwood & Palmer Inc. lifted its stake in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.32% of the stock is currently owned by insiders.

Humana Stock Performance

Shares of NYSE:HUM opened at $255.77 on Friday. The company’s 50 day simple moving average is $269.41 and its 200 day simple moving average is $290.00. The stock has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.38%. Humana’s dividend payout ratio (DPR) is 35.58%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and increased their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. TD Cowen increased their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $285.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.